Purpose of review: To improve our appreciation of the burden of chronic rhinosinusitis (CRS) and to understand better how to ease that burden.
Recent findings: The burden of CRS is high. At an individual level, this burden is due to rhinologic symptoms as well as more systemic symptoms. At a societal level, the indirect costs of CRS, mostly due to reduced productivity, are higher than the direct costs. Surgical treatment has been found to be effective in addressing both the individual and societal burdens. Endotyping is just beginning to usher in the potential for personalized, precision treatments in CRS. We understand much about the burden of CRS but more remains to be learned, especially as newer expensive treatments become available. By appreciating the high burden of CRS, we can fulfill our mission to effectively lift that burden.
Keywords: Chronic rhinosinusitis; Cost; Individual burden; Societal burden; Treatment.